Servier and n-Lorem Foundation join forces to advance research in rare neurodevelopmental disorders

Contributed by: PR Newswire

Tags

SERVIER-n-Lorem-Found

More Like This

PR Newswire associated0

n-Lorem and EspeRare announce European collaboration to expand access to individualized ASO Therapies for Rare Genetic Diseases

PR Newswire associated0

Servier and Base4 Expand Partnership to Advance Neuroscience Drug Development

PR Newswire associated0

Servier acquires potential treatment for Fragile X syndrome, the most common genetic cause of autism spectrum disorder

PR Newswire associated0

Servier and Day One Biopharmaceuticals announce acquisition to expand Servier's rare oncology portfolio

PR Newswire associated0

Servier's Voranigo® (vorasidenib) Receives Prix Galien Awards Across Multiple Regions

PR Newswire associated0

Servier to Acquire Edgewise Therapeutics' Muscular Dystrophy Business

PR Newswire associated0

Norgine strengthens rare disease portfolio with acquisition of Theravia

EQT Life Sciences invests in Asceneuron, a neurodegeneration therapeutics company, as part of USD 100 million Series C financing round